Blood-based traumatic brain injury biomarkers - Clinical utilities and regulatory pathways in the United States, Europe and Canada.
Kevin K W WangJennifer C Munoz ParejaStefania MondelloRamon Diaz-ArrastiaCheryl WellingtonKimbra KenneyAva M PuccioJamie HutchisonNicole McKinnonDavid O OkonkwoZhihui YangFiras KobeissyJ Adrian TyndallAndrás BükiEndre CzeiterMaria C Pareja ZabalaNithya GandhamRebecca Bermannull nullPublished in: Expert review of molecular diagnostics (2021)
TBI biomarker research has significantly advanced in the last decade. The recent approval of an iSTAT point of care test to detect mild TBI has paved the way for future biomarker clearance and appropriate clinical use across the globe.